Beida pharmaceutical: application for registration of first-line treatment indications of ensatinib hydrochloride accepted

Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May

Cbcirc: focus on investigating and dealing with the illegal transfer of interests through credit, bonds, discount and other means

Tonghua Dongbao: Notice of acceptance of the production declaration of engeliejing tablets

Jingke energy: it will be listed on the scientific innovation board on January 26

Dirui medical: recently obtained 11 medical device registration certificates

Boten Co., Ltd.: direnavir API has passed who PQ certification

Beida pharmaceutical: 4510000 shares pledged by Kaiming investment

TECO shares: obtained an invention patent certificate

Renrenle: it lost 365 million yuan in the first half of the year, closed 19 supermarket stores and opened 3 new ones

Zhongheng design: at the expiration of the reduction period, some executives have reduced 35000 shares in total

Dwell: shareholders Yang Jianmin and Lu Weidong plan to reduce their total shares by no more than 7.5%

The first bank of China fund to release its second Quarterly Report

Yonghe medical group submits listing application to HKEx

Beida pharmaceutical: clinical trial of batirizumab injection in the treatment of cervical cancer approved

Beida pharmaceutical: the three shareholders intend to reduce the shares of the company no more than 2.31%